Clinical Trials: Lowereing A1C, Weight Change & CV Data

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

PDF) Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks

Weight loss and benefits for cardiovascular disease (CVD)

Implications for treatment guidelines and future directions - Media Centre

Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes, Cardiovascular Diabetology

Incretins: How we got here, where we're at and what is coming next - DiabetesontheNet

The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk

Hemoglobin A1c Reduction and CV Risk Improvement: Correlation, Causation and Clinical Recommendations

A1C and Weight Change Results

JCM, Free Full-Text

The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2020

A1C and Weight Change Results

1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study

Mean A1c reduction in clinical studies of SGLT2 inhibitors

DECLARE-TIMI 58 – TIMI STUDY GROUP